Thanks to the generous support of Kidney Research UK, RaDaR will maintain it’s presence on the NIHR’s Research Portfolio until 31/03/2020. This ensures that recruiting sites will continue to receive financial support for every patient that they recruit to the rare disease registry.
The latest issue of the RaDaR Newsletter contains information about the recent NIHR Portfolio extension and details of up-coming events.
We are delighted to announce that the NIHR portfolio support for RaDaR has been renewed for the 2018-19 financial year, thanks to the generous support of Kidney Research UK. This provides accrual support for RaDaR up to 31/03/2019.